Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
Fernando IN, Bowden SJ, Herring K, Brookes CL, Ahmed I, Marshall A, Grieve R, Churn M, Spooner D, Latief TN, Agrawal RK, Brunt AM, Stevens A, Goodman A, Canney P, Bishop J, Ritchie D, Dunn J, Poole CJ, Rea DW; SECRAB Investigators. Fernando IN, et al. Among authors: rea dw. Radiother Oncol. 2020 Jan;142:52-61. doi: 10.1016/j.radonc.2019.10.014. Epub 2019 Nov 27. Radiother Oncol. 2020. PMID: 31785830 Free PMC article. Clinical Trial.
Adjuvant tamoxifen: how long before we know how long?
Rea D, Poole C, Gray R. Rea D, et al. BMJ. 1998 May 16;316(7143):1518-9. doi: 10.1136/bmj.316.7143.1518. BMJ. 1998. PMID: 9582148 Free PMC article. Review. No abstract available.
Endocrine therapy for early breast cancer.
Hussain SA, Williams S, Stevens A, Rea DW. Hussain SA, et al. Among authors: rea dw. Expert Rev Anticancer Ther. 2004 Oct;4(5):877-88. doi: 10.1586/14737140.4.5.877. Expert Rev Anticancer Ther. 2004. PMID: 15485321 Review.
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
Cullen M, Steven N, Billingham L, Gaunt C, Hastings M, Simmonds P, Stuart N, Rea D, Bower M, Fernando I, Huddart R, Gollins S, Stanley A; Simple Investigation in Neutropenic Individuals of the Frequency of Infection after Chemotherapy +/- Antibiotic in a Number of Tumours (SIGNIFICANT) Trial Group. Cullen M, et al. N Engl J Med. 2005 Sep 8;353(10):988-98. doi: 10.1056/NEJMoa050078. N Engl J Med. 2005. PMID: 16148284 Free article. Clinical Trial.
Role of chemotherapy in breast cancer.
Hussain SA, Palmer DH, Stevens A, Spooner D, Poole CJ, Rea DW. Hussain SA, et al. Among authors: rea dw. Expert Rev Anticancer Ther. 2005 Dec;5(6):1095-110. doi: 10.1586/14737140.5.6.1095. Expert Rev Anticancer Ther. 2005. PMID: 16336100 Review.
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
Poole CJ, Earl HM, Hiller L, Dunn JA, Bathers S, Grieve RJ, Spooner DA, Agrawal RK, Fernando IN, Brunt AM, O'Reilly SM, Crawford SM, Rea DW, Simmonds P, Mansi JL, Stanley A, Harvey P, McAdam K, Foster L, Leonard RC, Twelves CJ; NEAT Investigators and the SCTBG. Poole CJ, et al. Among authors: rea dw. N Engl J Med. 2006 Nov 2;355(18):1851-62. doi: 10.1056/NEJMoa052084. N Engl J Med. 2006. PMID: 17079759 Free article. Clinical Trial.
Molecularly targeted therapeutics for breast cancer.
Hussain SA, Palmer DH, Spooner D, Rea DW. Hussain SA, et al. Among authors: rea dw. BioDrugs. 2007;21(4):215-24. doi: 10.2165/00063030-200721040-00002. BioDrugs. 2007. PMID: 17628119 Review.
139 results